Results 91 to 100 of about 9,182 (184)

Utilization of Suprathel® in delayed surgical management of toxic epidermal necrolysis (TEN): A case report

open access: yesBurns Open
Given the lack of established practice guidelines for the management of cutaneous symptoms associated with toxic epidermal necrolysis, treatments range from various dressings to skin substitutes.
Isabella Lipkin   +2 more
doaj   +1 more source

A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis

open access: yesAnnals of Saudi Medicine, 2012
Toxic epidermal necrolysis represents an immunologic reaction to a foreign antigen and is most often caused by drugs. Atorvastatin, a blood cholesterol–lowering agent, is a recognized cause of rhabdomyolysis; while naproxen, a widely used nonsteroidal ...
Sheik Oaleed Noordally   +5 more
doaj   +1 more source

Ferroptosis: Newly Emerged Regulator for Human Disease

open access: yesMedComm, Volume 7, Issue 9, September 2026.
Ferroptosis is a key regulated cell death pathway closely involved in cancers, neurodegenerative disorders, acute organ injuries, and cardiovascular and chronic metabolic diseases, representing a promising therapeutic target for diverse human illnesses.
Dandan Xiao   +4 more
wiley   +1 more source

Risk Factors for Cutaneous Immune‐Related Adverse Events in the Japanese Population: A Retrospective Single‐Center Cohort Study

open access: yesThe Journal of Dermatology, Volume 53, Issue 9, Page 1245-1260, September 2026.
ABSTRACT Immune checkpoint inhibitor (ICI)‐driven alterations in the immune system can induce immune‐related adverse events (irAEs). Cutaneous irAEs are notable for being the most common and for their early onset; however, the risk factors underlying their development and severity remain unclear. In this study, we retrospectively analyzed 1224 Japanese
Tomoya Watanabe   +4 more
wiley   +1 more source

European Society of Contact Dermatitis Guideline for Diagnostic Patch Testing—Recommendations on Best Practice (Update 2026)

open access: yesContact Dermatitis, Volume 95, Issue 3, Page 237-275, September 2026.
ABSTRACT The present guideline updates the initial ESCD patch testing guideline, summarizing all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed‐type hypersensitivity skin and mucosal conditions. Sections with brief descriptions
Wolfgang Uter   +23 more
wiley   +1 more source

STEVENS-JOHNSON SYNDROME — TOXIC EPIDERMAL NECTROLYSIS IN CHILDREN. PART I. DETERMINATION, ETIOLOGY, PATHOGENESIS, CLINICAL MANIFESTATIONS, SYSTEMIC TREATMENT

open access: yesПедиатрическая фармакология, 2011
Part I of the literature review provides modern terminology and classification of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which is now considered different ways of treating the single pathological process induced in children ...
V.F. Zhernosek, T.P. Dyubkova
doaj   +2 more sources

Multidisciplinary management of antiepileptic drug-induced toxic epidermal necrolysis in a young woman

open access: yesBiomédica: revista del Instituto Nacional de Salud
Toxic epidermal necrolysis is a rare, life-threatening dermatological emergency characterized by extensive epidermal detachment and mucosal involvement,  associated with high morbidity and mortality.
Salman Khan, Priti Singh, Rana Salieva
doaj   +1 more source

Exploring skin adverse events and mechanisms of apalutamide using data mining algorithms and network pharmacology

open access: yesFrontiers in Pharmacology
BackgroundSkin adverse events of apalutamide pose a major challenge to its clinical use, particularly the severe and difficult to identify toxic epidermal necrolysis.
Yaqing Chen   +4 more
doaj   +1 more source

Toxic Epidermal Necrolysis

open access: yesInternational Journal of Clinical Practice, 1967
M J, Samuels, M D, Readett
openaire   +2 more sources

Intrapartum Toxic Epidermal Necrolysis [PDF]

open access: yesArchives of Disease in Childhood, 1964
W P, SWEETNAM, A J, BARLOW, R G, DENNISS
openaire   +2 more sources

Home - About - Disclaimer - Privacy